S&P 500   3,323.63 (+0.06%)
DOW   29,164.85 (-0.07%)
QQQ   224.38 (+0.22%)
AAPL   318.96 (+0.40%)
FB   220.34 (-0.44%)
MSFT   166.17 (+0.28%)
GOOGL   1,486.65 (+0.17%)
AMZN   1,887.00 (-0.02%)
NVDA   252.78 (+1.09%)
BABA   219.53 (-1.28%)
MU   59.27 (+0.15%)
GE   11.80 (+3.78%)
TSLA   572.58 (+0.53%)
AMD   51.63 (+0.39%)
T   38.68 (-0.95%)
F   9.11 (-0.55%)
NFLX   343.09 (+5.24%)
BAC   34.23 (-0.38%)
DIS   142.07 (-1.35%)
S&P 500   3,323.63 (+0.06%)
DOW   29,164.85 (-0.07%)
QQQ   224.38 (+0.22%)
AAPL   318.96 (+0.40%)
FB   220.34 (-0.44%)
MSFT   166.17 (+0.28%)
GOOGL   1,486.65 (+0.17%)
AMZN   1,887.00 (-0.02%)
NVDA   252.78 (+1.09%)
BABA   219.53 (-1.28%)
MU   59.27 (+0.15%)
GE   11.80 (+3.78%)
TSLA   572.58 (+0.53%)
AMD   51.63 (+0.39%)
T   38.68 (-0.95%)
F   9.11 (-0.55%)
NFLX   343.09 (+5.24%)
BAC   34.23 (-0.38%)
DIS   142.07 (-1.35%)
S&P 500   3,323.63 (+0.06%)
DOW   29,164.85 (-0.07%)
QQQ   224.38 (+0.22%)
AAPL   318.96 (+0.40%)
FB   220.34 (-0.44%)
MSFT   166.17 (+0.28%)
GOOGL   1,486.65 (+0.17%)
AMZN   1,887.00 (-0.02%)
NVDA   252.78 (+1.09%)
BABA   219.53 (-1.28%)
MU   59.27 (+0.15%)
GE   11.80 (+3.78%)
TSLA   572.58 (+0.53%)
AMD   51.63 (+0.39%)
T   38.68 (-0.95%)
F   9.11 (-0.55%)
NFLX   343.09 (+5.24%)
BAC   34.23 (-0.38%)
DIS   142.07 (-1.35%)
S&P 500   3,323.63 (+0.06%)
DOW   29,164.85 (-0.07%)
QQQ   224.38 (+0.22%)
AAPL   318.96 (+0.40%)
FB   220.34 (-0.44%)
MSFT   166.17 (+0.28%)
GOOGL   1,486.65 (+0.17%)
AMZN   1,887.00 (-0.02%)
NVDA   252.78 (+1.09%)
BABA   219.53 (-1.28%)
MU   59.27 (+0.15%)
GE   11.80 (+3.78%)
TSLA   572.58 (+0.53%)
AMD   51.63 (+0.39%)
T   38.68 (-0.95%)
F   9.11 (-0.55%)
NFLX   343.09 (+5.24%)
BAC   34.23 (-0.38%)
DIS   142.07 (-1.35%)
Log in
(Ad)
Did you know that you could generate up to $1,529.70 in passive income per month without risking your retirement? A virtually unheard-of investment plan is finally letting everyday Americans invest in cannabis without betting the house. The best part? This plan has been around for over 50 years!

NASDAQ:OMCL - Omnicell Stock Price, Forecast & News

$86.55
-0.17 (-0.20 %)
(As of 01/23/2020 02:56 PM ET)
Today's Range
$85.55
Now: $86.55
$86.77
50-Day Range
$79.69
MA: $82.41
$87.50
52-Week Range
$62.40
Now: $86.55
$92.59
Volume8,889 shs
Average Volume154,217 shs
Market Capitalization$3.63 billion
P/E Ratio68.15
Dividend YieldN/A
Beta1.12
Omnicell, Inc provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence. The Automation and Analytics segment offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. Read More…

Industry, Sector and Symbol

Industry Electronic computers
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:OMCL
CUSIP68213N10
Phone650-251-6100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$787.31 million
Cash Flow$2.90 per share
Book Value$17.15 per share

Profitability

Net Income$37.73 million

Miscellaneous

Employees2,480
Market Cap$3.63 billion
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive OMCL News and Ratings via Email

Sign-up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

2020 could be a monster year for cannabis stocks, especially with cannabis on many November ballots, and presidential candidates pushing for approval. In our latest special report, we detail five must-own cannabis stocks that could double, even triple your investment over the next year.

Omnicell (NASDAQ:OMCL) Frequently Asked Questions

What is Omnicell's stock symbol?

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

How were Omnicell's earnings last quarter?

Omnicell, Inc. (NASDAQ:OMCL) posted its earnings results on Thursday, October, 24th. The company reported $0.76 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.71 by $0.05. The company earned $228.80 million during the quarter, compared to the consensus estimate of $231.86 million. Omnicell had a net margin of 6.28% and a return on equity of 11.90%. The company's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.63 earnings per share. View Omnicell's Earnings History.

When is Omnicell's next earnings date?

Omnicell is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Omnicell.

What price target have analysts set for OMCL?

7 analysts have issued 12 month price objectives for Omnicell's stock. Their forecasts range from $70.00 to $95.00. On average, they expect Omnicell's stock price to reach $85.57 in the next twelve months. This suggests that the stock has a possible downside of 1.1%. View Analyst Price Targets for Omnicell.

What is the consensus analysts' recommendation for Omnicell?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Omnicell.

Has Omnicell been receiving favorable news coverage?

News headlines about OMCL stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Omnicell earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Omnicell.

Are investors shorting Omnicell?

Omnicell saw a drop in short interest in December. As of December 13th, there was short interest totalling 2,100,000 shares, a drop of 7.9% from the November 28th total of 2,280,000 shares. Based on an average daily volume of 239,800 shares, the short-interest ratio is presently 8.8 days. Approximately 5.1% of the shares of the stock are sold short. View Omnicell's Current Options Chain.

Who are some of Omnicell's key competitors?

What other stocks do shareholders of Omnicell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), AbbVie (ABBV), Netflix (NFLX), NVIDIA (NVDA), Alibaba Group (BABA), Bank of America (BAC), Johnson & Johnson (JNJ), Adobe (ADBE), Gilead Sciences (GILD) and Micron Technology (MU).

Who are Omnicell's key executives?

Omnicell's management team includes the folowing people:
  • Mr. Randall A. Lipps, Founder, Exec. Chairman, Pres & CEO (Age 62)
  • Mr. Peter J. Kuipers, Exec. VP & CFO (Age 47)
  • Mr. Daniel S. Johnston, Exec. VP, Chief Legal & Admin. Officer and Corp. Sec. (Age 55)
  • Mr. Joseph Brian Spears, VP of Corp. Fin. & Chief Accounting Officer (Age 59)
  • Mr. Nhat H. Ngo, Exec. VP of Marketing, Strategy & Bus. Devel. (Age 46)

Who are Omnicell's major shareholders?

Omnicell's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Peregrine Capital Management LLC (0.71%), Tributary Capital Management LLC (0.63%), Summit Creek Advisors LLC (0.63%), Scout Investments Inc. (0.43%), Rhenman & Partners Asset Management AB (0.23%) and Calamos Advisors LLC (0.13%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann. View Institutional Ownership Trends for Omnicell.

Which institutional investors are selling Omnicell stock?

OMCL stock was sold by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, Tributary Capital Management LLC, Scout Investments Inc., Assenagon Asset Management S.A., Louisiana State Employees Retirement System, State of Alaska Department of Revenue and West Coast Financial LLC. Company insiders that have sold Omnicell company stock in the last year include Dan S Johnston, Gary S Petersmeyer, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps and Scott Peter Seidelmann. View Insider Buying and Selling for Omnicell.

Which institutional investors are buying Omnicell stock?

OMCL stock was purchased by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Peregrine Capital Management LLC, DNB Asset Management AS, Calamos Advisors LLC, Rhenman & Partners Asset Management AB, Rothschild Investment Corp IL, First National Bank of Omaha and SFE Investment Counsel. View Insider Buying and Selling for Omnicell.

How do I buy shares of Omnicell?

Shares of OMCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Omnicell's stock price today?

One share of OMCL stock can currently be purchased for approximately $86.49.

How big of a company is Omnicell?

Omnicell has a market capitalization of $3.63 billion and generates $787.31 million in revenue each year. The company earns $37.73 million in net income (profit) each year or $1.53 on an earnings per share basis. Omnicell employs 2,480 workers across the globe.View Additional Information About Omnicell.

What is Omnicell's official website?

The official website for Omnicell is http://www.omnicell.com/.

How can I contact Omnicell?

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The company can be reached via phone at 650-251-6100 or via email at [email protected]


MarketBeat Community Rating for Omnicell (NASDAQ OMCL)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  435 (Vote Outperform)
Underperform Votes:  337 (Vote Underperform)
Total Votes:  772
MarketBeat's community ratings are surveys of what our community members think about Omnicell and other stocks. Vote "Outperform" if you believe OMCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: What is a back-end load?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel